Security Snapshot

NEOGENOMICS INC - NOTE 0.250% 1/1 Institutional Ownership

CUSIP: 64049MAB6

13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

21

Principal

$344,881,000

Price (% of par)

91.5%

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 3 signals
Principal change
-$1,294,000
Market value change
-$626,840
Number of holders
21
Issuer context Who this page is about. 1 identity field
SEC-reported market price (% of par)
91.5%
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • 64049MAB6 - NEOGENOMICS INC - NOTE 0.250% 1/1 is tracked under CUSIP 64049MAB6.
  • 21 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 21 to 21 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $310,349,378 to $317,337,315.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 21 institutions filings for Q1 2026.

Open SEC evidence

Security key

64049MAB6

Latest holder period

Q1 2026

13F holders

21

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 21 institutional investors reported holding $344,881,000 in principal (par value) of NEOGENOMICS INC - NOTE 0.250% 1/1.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
21
Latest
Q1 2026
Rows shown
1-21 of 21
Period Principal Value Change Price (% of par) (Median) Investors
2026 Q1 $344,881,000 $317,337,315 -$626,840 91.5% 21
2025 Q4 $346,175,000 $310,349,378 +$981,480 89.26% 21
2025 Q3 $345,063,000 $300,247,353 -$1,047,258 86.5% 21
2025 Q2 $347,424,500 $298,701,017 +$1,329,076 85.38% 24
2025 Q1 $345,968,500 $300,355,654 +$507,793 86.32% 24
2024 Q4 $346,156,500 $292,693,370 -$7,990,591 84.0% 27
2024 Q3 $356,060,500 $296,374,577 +$17,437,220 82.86% 28
2024 Q2 $335,580,500 $263,497,607 +$1,308,070 78.17% 28
2024 Q1 $333,774,500 $266,976,531 +$1,456,937 79.75% 25
2023 Q4 $333,400,500 $253,694,214 +$3,165,777 75.6% 30
2023 Q3 $329,987,000 $237,042,492 -$556,393 71.53% 28
2023 Q2 $330,413,000 $243,310,105 -$296,237 73.32% 32
2023 Q1 $330,802,000 $244,199,793 +$1,969,797 73.51% 30
2022 Q4 $331,631,000 $215,226,340 +$776,251 64.63% 33
2022 Q3 $277,556,500 $183,092,769 -$26,084,301 64.64% 31
2022 Q2 $318,858,347 $202,728,341 +$10,098,000 62.13% 30
2022 Q1 $298,643,089 $201,340,104 -$2,525,738 66.57% 36
2021 Q4 $293,181,906 $250,805,827 -$23,948,051 85.41% 31
2021 Q3 $320,195,500 $323,656,284 +$11,107,101 101.13% 33
2021 Q2 $308,715,774 $302,787,253 +$10,622,528 97.62% 29
2021 Q1 $298,991,370 $302,575,255 +$302,575,255 101.11% 38
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .